- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07628673
The Effectiveness of a Digital Career-Focused Mobile Application on Nursing Students' Career Planning and Career Trajectories: A Randomized Controlled Trial (NurseBridge)
1. juni 2026 oppdatert av: Chang Gung Memorial Hospital
Methods: This three-year experimental study is divided into two phases.
In the first phase, a mixed-methods approach will be used.
During this phase, a mobile application based on the Career Planning Model will be developed, followed by a pilot study to perform user testing and evaluate usability.
The second phase will employ a prospective, double-blind randomized controlled trial (RCT) design, utilizing the nursing career planning application developed in the first phase for a six-month intervention study.
A total of 108 senior-year nursing students (54 in the intervention group and 54 in the control group) will be invited to participate inthe study.
Studieoversikt
Status
Har ikke rekruttert ennå
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
148
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Hsing-Yi Yu, PhD
- Telefonnummer: +886-928-518-616
- E-post: kanano@gmail.com
Studiesteder
-
-
Guishan
-
Taoyuan, Guishan, Taiwan, 33302
- Chang Gung University
-
Ta kontakt med:
- Hsing-Yi Yu, PhD
- Telefonnummer: +886-928-518-616
- E-post: kanano@gmail.com
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Inclusion criteria for study participants: 1. Currently in their final year of nursing studies (including five-year vocational colleges, four-year technical colleges, and universities). 2. Possess a mobile phone with internet access. 3. Be of sound mind and able to understand and answer researchers' questions. 4. Be able to understand spoken or written Chinese. 5. Be willing to participate in this study and sign a participant consent form.
Exclusion Criteria:
- Exclusion criteria: 1. Nursing two-year technical college students. 2. Those with full-time or part-time clinical nursing work experience. 3. Those unwilling to participate in this study. 4. Those unable to download the app.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental Group
Participants will engage in a career planning action application for nursing students for six months.
|
Career planning action application for nursing students (6 months)
|
|
Ingen inngripen: Control Group
receive the usual career development course
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
career self-efficacy score
Tidsramme: To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
This study will use the Career Decision Self-Efficacy Scale-Short Form (CDMSE-SF) to evaluate nursing students' confidence in their ability to successfully perform career decision-making tasks and overcome barriers related to career decision-making.
|
To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
|
career planning behaviors
Tidsramme: To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
This study will use the Career Planning Scale to assess nursing students' readiness for the career planning process, reflecting their level of career maturity.
|
To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
|
career resilience
Tidsramme: To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
This study will use the Adolescent Career Resilience Scale (ACRS) to assess nursing students' career resilience.
|
To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
|
professional identity
Tidsramme: To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
This study will use the Nurses' Professional Identity Scale to assess nursing students' professional identity.
|
To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
|
nursing career persistence intentions.
Tidsramme: To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
Career persistence intention will be measured using a single-item 10-point Numeric Rating Scale (NRS): "I intend to continue pursuing a career in nursing," with 1 indicating strongly disagree and 10 indicating strongly agree.
|
To evaluate the trajectory of outcomes at different time points, data will be collected in five waves: before the intervention and at 0, 3, 6, and 12 months post-intervention.
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. juli 2026
Primær fullføring (Antatt)
31. juli 2029
Studiet fullført (Antatt)
30. oktober 2029
Datoer for studieregistrering
Først innsendt
1. juni 2026
Først innsendt som oppfylte QC-kriteriene
1. juni 2026
Først lagt ut (Faktiske)
5. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
5. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
1. juni 2026
Sist bekreftet
1. mai 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 202500369B0C6001
- NSTC 114-2410-H-182 -012 -MY2 (Annet stipend/finansieringsnummer: National Science and Technology Council (NSTC))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
IPD-planbeskrivelse
Individual participant data (IPD) will not be shared to protect participant confidentiality and privacy, in accordance with institutional review board requirements and informed consent provisions.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Nurse Bridge App
-
Insel Gruppe AG, University Hospital BernUniversity of BernRekrutteringBarnefedme | Fedme hos ungdom | Fethet | Ikke-smittsom sykdom | Livsstil | Atferd, helse | Oppførsel, spisingSveits
-
London School of Hygiene and Tropical MedicineFullførtErnæring | Bærekraft | Mobil helseteknologi (mHealth)Storbritannia
-
Northwestern UniversityNational Institute of Mental Health (NIMH); Rush UniversityFullført
-
Institute for Human Development and Potential (IHDP)...Aktiv, ikke rekrutterendeType 2 diabetes | Svangerskapsdiabetes | Sunn livsstilSingapore
-
Click Therapeutics, Inc.FullførtLeddgikt | Irritabel tarm-syndrom | Fibromyalgi | Diabetisk nevropatiForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TilbaketrukketOndartet fast neoplasma | Sarkom | Hodgkin lymfom | Non-Hodgkin lymfom | Neoplasma i sentralnervesystemetForente stater
-
Yale UniversityNational Institute on Drug Abuse (NIDA); American Heart AssociationFullført
-
University of California, San FranciscoConquer Cancer FoundationFullførtProstatakreft | Metastatisk prostatakreft | Metastatisk kastrasjonsresistent prostatakreftForente stater
-
University of South CarolinaFullførtOvervekt og fedme | Pre-diabetesForente stater
-
Hypnalgesics, LLCTufts UniversityFullførtTannlege angst | Opioidbruk | Narkotika bruk | TannsmerterForente stater